Acute Epididymoorchitis Management in HIV-Positive Patient
This 34-year-old man with well-controlled HIV presenting with unilateral scrotal pain, erythema, and fever most likely has acute epididymoorchitis and should undergo immediate scrotal ultrasound with Doppler to exclude testicular torsion, followed by empiric antibiotic therapy covering both gonorrhea and chlamydia while awaiting diagnostic test results. 1
Immediate Diagnostic Evaluation
Imaging Priority
- Scrotal ultrasound with Doppler is the first-line imaging modality to differentiate epididymoorchitis from testicular torsion, which requires emergent surgical intervention 1
- Epididymoorchitis is the most common cause of acute scrotum in adult men, but testicular torsion must be excluded first given the overlapping clinical presentations 1
- The ultrasound will show increased blood flow in epididymoorchitis versus decreased/absent flow in torsion 1
Laboratory Testing
- Obtain urethral swab or first-void urine for nucleic acid amplification tests (NAATs) for both Neisseria gonorrhoeae and Chlamydia trachomatis 1
- NAATs are preferred over culture due to higher sensitivity 1
- Urinalysis with microscopy should demonstrate ≥10 WBC per high-power field or positive leukocyte esterase 1
- HIV-positive men should be screened for syphilis concurrently given increased STI risk 2
Empiric Antibiotic Treatment
Start Immediately After Imaging
Do not delay antibiotics while awaiting test results if clinical suspicion is high 1
Recommended Regimen for Sexually Active Adults
- Ceftriaxone 500 mg IM single dose (for gonorrhea coverage)
- PLUS Doxycycline 100 mg orally twice daily for 10 days (for chlamydia coverage) 1
Alternative if Doxycycline Contraindicated
- Ceftriaxone 500 mg IM single dose
- PLUS Azithromycin 1 g orally single dose 1
Note: While azithromycin offers single-dose convenience, doxycycline is preferred for epididymoorchitis due to better tissue penetration and coverage of Mycoplasma genitalium 1
HIV-Specific Considerations
Clinical Presentation Nuances
- STIs may have atypical presentations in HIV-positive patients, though this patient has well-controlled HIV which reduces this risk 3, 2
- Well-controlled HIV (presumably on ART with undetectable viral load) should not significantly alter the clinical presentation or treatment approach 3
Enhanced Screening Requirements
- HIV-positive men should undergo annual screening for urogenital gonorrhea and chlamydia regardless of symptoms 2
- If the patient reports receptive anal intercourse, also screen for rectal gonorrhea and chlamydia 2
- More frequent screening (every 3-6 months) is indicated for men with multiple or anonymous partners 2
Partner Management and Follow-Up
Sexual Partner Notification
- All sexual partners from the preceding 60 days must be evaluated and treated empirically 1
- Partners should receive the same antibiotic regimen even if asymptomatic 1
Patient Instructions
- Abstain from sexual intercourse for 7 days after completing therapy and until symptoms resolve 1
- Abstain until all partners have been treated to prevent reinfection 1
Follow-Up Testing
- Test-of-cure is not routinely recommended for chlamydia or gonorrhea unless symptoms persist 1
- However, retest in 3 months is recommended due to high reinfection rates 1
Common Pitfalls to Avoid
Critical Diagnostic Errors
- Failing to exclude testicular torsion before initiating antibiotics - torsion requires surgery within 6 hours to salvage the testicle 1, 4
- Relying solely on clinical examination without ultrasound confirmation - physical findings overlap significantly between conditions 1
Treatment Mistakes
- Starting single-agent therapy without dual coverage for both gonorrhea and chlamydia 1
- Using fluoroquinolones as first-line therapy - resistance rates are too high for gonorrhea 1
- Neglecting partner treatment, which leads to reinfection rates exceeding 20% 1